Cancer Institute– A national cancer institute
designated cancer center

Douglas W. Blayney

Back to Profile

Publication Details

  • Adoption of gene expression profile testing and association with use of chemotherapy among women with breast cancer.

    Hassett MJ, Silver SM, Hughes ME, Blayney DW, Edge SB, Herman JG, Hudis CA, Marcom PK, Pettinga JE, Share D, Theriault R, Wong YN, Vandergrift JL, Niland JC, Weeks JC. J Clin Oncol. 2012; 30 (18): 2218-26

    Gene expression profile (GEP) testing is a relatively new technology that offers the potential of personalized medicine to patients, yet little is known about its adoption into routine practice. One of the first commercially available GEP tests, a 21-gene profile, was developed to estimate the benefit of adjuvant chemotherapy for hormone receptor-positive breast cancer (HR-positive BC).

    PubMedID: 22585699

Stanford Medicine Resources:

Footer Links: